Current options for the management of rectal cancer

Current Treatment Options in Oncology

Volumn 8, Issue 5, 2007, Pages 331-338

  O'Neil, Bert H ^a   Tepper, Joel E ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; VASCULOTROPIN RECEPTOR; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FOLFOX PROTOCOL; PLATINUM COMPLEX;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLOSTOMY; DRUG SAFETY; DRUG TARGETING; HIGH RISK PATIENT; HUMAN; ILEOSTOMY; INTERMETHOD COMPARISON; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; RADIOSENSITIZATION; RECTUM ANASTOMOSIS; RECTUM CANCER; RECTUM CARCINOMA; RECTUM SURGERY; RECURRENCE RISK; RECURRENT CANCER; REVIEW; RISK REDUCTION; SURGICAL APPROACH; THERAPY DELAY; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RECTUM TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; ENDOSONOGRAPHY; FLUOROURACIL; HUMANS; LEUCOVORIN; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 43549089516     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-007-0048-7     Document Type: Review

References (51)

1. American Cancer Society: Cancer Facts & Figures, Vol. 1951. New York: American Cancer Society; 2007
2. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985, 312 (23):1465-1472
3. Krook JE, et al. (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324(11):709-715
4. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. J Clin Oncol 1992, 10 (4):549-557
5. O'Connell MJ, et al., Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med, 1994 331 (8): 502-507
6. Sahani DV, Kalva SP, Hahn PF. (2003) Imaging of rectal cancer. Semin Radiat Oncol 13(4): 389-402
7. Salerno G, et al. (2006) Clarifying margins in the multidisciplinary management of rectal cancer: The MERCURY experience. Clin Radiol 61(11): 916-923
8. Fortier GA, et al. (1986) Dose response to preoperative irradiation in rectal cancer: Implications for local control and complications associated with sphincter sparing surgery and abdominoperineal resection. Int J Radiat Oncol Biol Phys 12(9): 1559-1563
9. Temple LK, et al. (2005) The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum 48(7):1353-1365
10. Temple LK, WD Wong, B Minsky, The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol, 2003. 13 (4): P. 469-477
11. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997, 336 (14):980-987
12. Heald RJ, Ryall RD. (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496): 1479-1482
13. Nagtegaal ID, van Krieken JHJM: The multidisciplinary treatment of rectal cancer: Pathology. Ann Oncol 20I7 Jul, 18(Suppl 9): ix122-126
14. Kapiteijn E, et al. (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9): 638-646
15. Balslev I, et al. (1986) Major or local surgery for cure in early rectal and sigmoid carcinoma - a prospective evaluation. Eur J Surg Oncol 12(4): 373-377
16. Buess G, et al.: Technique and results of transanal endoscopic microsurgery in early rectal cancer. Am J Surg, 1992. 163 (1): 63-69; discussion 69-70
17. Rosenthal SA, et al. (1992) Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy. A report of a phase I-II trial. Cancer 69(2): 335-341
18. Minsky BD, et al., Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer, 1989. 63 (7): P. 1421-1429
19. You YN, et al. (2007) Is the increasing rate of local excision for stage I rectal cancer in the United States justified? a nationwide cohort study from the National Cancer Database. Ann Surg 245(5):726-733
20. Meyerhardt JA, et al. (2004) Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: Findings from the Intergroup 0114 Study. J Clin Oncol 22(1): 166-174
21. Schrag D, et al. (2002) Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg 236(5): 583-592
22. Sauer R, et al., Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004. 351(17): P. 1731-1740
23. Birgisson H, et al. (2005) Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23(34):8697-8705
24. Gunderson LL, et al. (2002) Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: A pooled analysis. Int J Radiat Oncol Biol Phys 54(2):386-396
25. Gunderson LL, et al., Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol, 2004. 22 (10): P. 1785-1796
26. Clinico -pathological features of prognostic significance in operable rectal cancer in 17 centres in the U.K. (Third report of the M.R.C. Trial, on behalf of the Working Party). Br J Cancer 1984, 50 (4):435-442
27. Leo E, et al. (1994) Total rectal resection and colo-anal anastomosis for low rectal tumours: Comparative results in a group of young and old patients. Eur J Cancer 30A(8): 1092-1095
28. Marks G, Mohiuddin M, Masoni L. (1993) The reality of radical sphincter preservation surgery for cancer of the distal 3 cm of rectum following high-dose radiation. Int J Radiat Oncol Biol Phys 27(4): 779-783
29. Minsky BD, AM Cohen, Conservative management of invasive rectal cancer: alternative to abdominoperineal resection. Oncology (Williston Park), 1989. 3 (5): P. 137-142; discussion 142, 146-148
30. Steele G, Jr., et al., A pilot study of sphincter-sparing management of adenocarcinoma of the rectum. Arch Surg, 1991. 126 (6): P. 696-701; discussion 701-702
31. Bosset JF, et al. (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11):1114-23
32. Beaven AW, RM Goldberg, Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow. Oncology (Williston Park), 2006. 20 (5): p. 461-469; discussion 469-470, 473-475
33. Andre T, et al. (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23): 2343-2351
34. Wolmark N, et al.: A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Results of NSABP Protocol C-07. J Clin Oncol, ASCO Annual Meeting Proceedings 2005, 23(16S): LBA 3500
35. de Gramont A, et al.: Oxaliplatin/5FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years. J Clin Oncol, ASCO Annual Meeting Proceedings 2007, 25(18S): Abstract 4007
36. Adam R. (2007) Colorectal cancer with synchronous liver metastases. Br J Surg 94(2):129-131
37. Benoist S, et al. (2005) Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92(9):1155-1160
38. Scoggins CR, et al. (1999) Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 6(7): 651-657
39. Tepper JE, et al. (2003) Analysis of surgical salvage after failure of primary therapy in rectal cancer: Results from Intergroup Study 0114. J Clin Oncol 21(19): 3623-3628
40. Nordlinger B, et al.: Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol, ASCO Annual Meeting Proceedings 2007, 25(18S): LBA 5
41. Alberts SR, et al. (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23(36): 9243-9249
42. Willeke F, et al. (2007) A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer. Br J Cancer 96(6): 912-917
43. Voelter V, et al. (2006) CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: Results from a phase II. Br J Cancer 95(6):710-716
44. Navarro M, et al. (2006) A phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66(1):201-205
45. Mohiuddin M, et al. (2006) Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24(4):650-655
46. Rodel C, et al. (2007) Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 25(1):110-117
47. Ryan DP, et al. (2006) Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 24(16):2557-2562
48. Chau I, et al. (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24(4): 668-674
49. Machiels JP, et al. (2007) Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol 18(4):738-744
50. Krishnan S, et al. (2006) Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66(3):762-771
51. De Paoli A, et al. (2006) Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: A multicentric phase II study. Ann Oncol 17(2):246-251